Abstracts tagged "Arthritis and outcomes"

Abstract Number: 1690 • 2019 ACR/ARP Annual Meeting
The Long-term Outcome of Patients with Arthritis of Behçet’s Disease
Hirotoshi Kikuchi¹, Takafumi Tomizuka ¹, Kurumi Asako ¹, Hajime Kono ¹ and Shunsei Hirohata ², ¹Teikyo University School of Medicine, Tokyo, Japan, ²Nobuharra Hospital & Institute of Biomechanics, Tokyo, Japan
Background/Purpose: Behçet’s disease (BD) is characterized by recurrent aphthous stomatitis, eye lesions, skin lesions, and genital ulcer. In addition to these symptoms, Behçet’s disease is…
Abstract Number: 2035 • 2014 ACR/ARHP Annual Meeting
Joint Distribution and Outcome in 350 Patients with Monoarthritis of Less Than 16 Weeks Duration: Data from a Multicenter Longitudinal Observational Study in Eastern Norway
Ellen Sauar Norli^1,2, Gina Hetland Brinkmann^1,3, Tore K. Kvien¹, Olav Bjørneboe⁴, Anne Julsrud Haugen³, Halvor Nygaard⁵, Cathrine Thunem⁶, Elisabeth Lie¹ and Maria Dahl Mjaavatten¹, ¹Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Dept. of Rheumatology, Martina Hansens Hospital, Sandvika, Norway, ³Dept. of Rheumatology, Østfold Hospital Trust, Fredrikstad, Norway, ⁴Dept. of Rheumatology, Martina Hansens Hospital, Sandvika, Norway, ⁵Dept. of Rheumatology, Revmatismesykehuset Lillehammer, Lillehammer, Norway, ⁶Dept. of Rheumatology, Betanien Hospital, Skien, Norway
Background/Purpose: Cohort studies are essential to provide better understanding of the prognosis of acute monoarthritis, but few studies have focused on this issue. Our objective…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].